Related Experiment Videos
Two differentially expressed genes in normal human prostate tissue and in carcinoma
1Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massauchesetts 02115, USA.
Cancer Research
|August 15, 1996
Summary
Prostate cancer cells show altered gene expression, with decreased human epithelial tropomyosin (TMe1) and increased cytochrome c oxidase subunit VIc (COSVIc). COSVIc may serve as a diagnostic marker for prostate cancer and altered energy metabolism.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Transcriptional control alterations are implicated in carcinogenesis.
- Prostate cancer involves changes in gene expression patterns.
Purpose of the Study:
- To identify differentially expressed genes in prostate cancer cells compared to normal cells.
- To investigate the potential of identified genes as biomarkers for prostate cancer diagnosis and metabolic alterations.
Main Methods:
- Differential display technique to identify gene expression differences.
- Northern hybridization to confirm gene expression patterns.
- In situ hybridization to localize mRNA expression in tissues.
Main Results:
- Human epithelial tropomyosin (TMe1) was found to be down-regulated in prostate cancer cells.
- Cytochrome c oxidase subunit VIc (COSVIc) was found to be up-regulated in prostate cancer cells.
- COSVIc mRNA showed strong expression in malignant prostate tissue, with weak expression in normal tissue.
Conclusions:
- COSVIc expression is significantly altered in prostate cancer.
- COSVIc may be a valuable marker for understanding energy metabolism changes in cancer.
- COSVIc holds potential as a diagnostic marker for prostate cancer.